EXOCRINE PANCREATIC ADENOCARCINOMA
Clinical trials for EXOCRINE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXOCRINE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for EXOCRINE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug sigvotatug vedotin enters human trials
Disease control Recruiting nowThis early-stage trial is testing a new drug called sigvotatug vedotin, alone or with other cancer medicines, in people with advanced solid tumors like lung, head and neck, and breast cancers. The study aims to find a safe dose and check for side effects. About 1,000 participants…
Matched conditions: EXOCRINE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Pancreatic cancer study digs into tumor DNA to unlock clues
Knowledge-focused Recruiting nowThis study looks at tumor samples from 300 people with exocrine pancreatic cancer to find links between genetic changes in the tumor and how the disease behaves. Researchers will use advanced DNA sequencing to analyze samples already collected from surgeries and biopsies. The goa…
Matched conditions: EXOCRINE PANCREATIC ADENOCARCINOMA
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC